WELLESLEY HILLS, Mass., Dec. 8 /PRNewswire/ -- Joseph F. Finn, Jr., C.P.A. Managing Partner of Finn, Warnke & Gayton announced today that the firm is offering a sales platform for biotechnology companies to sell their intellectual property. According to industry sources, many of these enterprises have intellectual property sitting dormant in various stages of development due to funding, scientific or regulatory issues.
Finn noted that the firm's experience in selling the intellectual property of ActivBiotics, Spherics, Prospect Therapeutics, Alpha Beta Technologies and Epix Pharmaceuticals has given it the opportunity to develop a database of active buyers and create a legal platform to conduct sales. It has also created a steady flow of inquires from biotech firms and individuals regarding the firm's future offerings of intellectual property.
Persons interested in discussing this service should contact Joseph F. Finn, Jr., Christopher J. Finn, or Paul Bolger at 781-237-8840 or Link';s.eVar3=s.prop5;s.prop15='78779862';s.tl(this,'o','ExternalLink');">firstname.lastname@example.org.
About Finn, Warnke & Gayton
For over 35 years, Finn, Warnke & Gayton has been one of the region's most respected business consulting and accounting firms. In addition to our new service, our team of professionals provides management consulting services to distressed enterprises, accounting, trustee, and agency services related to bankruptcy and insolvency matters, advisory services to financial institutions, interim management, and traditional tax and accounting services to corporations and individuals. For more information on the firm, please visit our website at Link';s.eVar3=s.prop5;s.prop15='78779862';s.tl(this,'o','ExternalLink');">finnwarnkegayton.com.
SOURCE Finn, Warnke & Gayton
|SOURCE Finn, Warnke & Gayton|
Copyright©2009 PR Newswire.
All rights reserved